Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Garofalo Health Care S.p.A. (GHC.F)

Compare
5.04
0.00
(0.00%)
As of April 9 at 3:29:01 PM GMT+2. Market Open.
Loading Chart for GHC.F
  • Previous Close 5.04
  • Open 4.82
  • Bid 4.82 x --
  • Ask 5.43 x --
  • Day's Range 4.82 - 5.04
  • 52 Week Range 4.43 - 5.96
  • Volume 132
  • Avg. Volume 0
  • Market Cap (intraday) 451.921M
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) 21.00
  • EPS (TTM) 0.24
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Garofalo Health Care S.p.A., together with its subsidiaries, operates healthcare clinics in Italy. It operates through Hospital and Social/Dependency Care segments. The company offers high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and nutritional rehabilitation. It also operates centers for patients in coma and persistent vegetative states; and psychiatric and diagnostic centers. Garofalo Health Care S.p.A. was founded in 2000 and is based in Rome, Italy. Garofalo Health Care S.p.A. is a subsidiary of Larama 98 S.p.A.

www.garofalohealthcare.com

2,767

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GHC.F

View More

Performance Overview: GHC.F

Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is FTSE MIB Index (FTSEMIB.MI) .

YTD Return

GHC.F
5.97%
FTSE MIB Index (FTSEMIB.MI)
4.26%

1-Year Return

GHC.F
1.82%
FTSE MIB Index (FTSEMIB.MI)
3.58%

3-Year Return

GHC.F
3.60%
FTSE MIB Index (FTSEMIB.MI)
31.88%

5-Year Return

GHC.F
0.80%
FTSE MIB Index (FTSEMIB.MI)
85.74%

Compare To: GHC.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GHC.F

View More

Valuation Measures

Annual
As of 4/8/2025
  • Market Cap

    451.92M

  • Enterprise Value

    647.35M

  • Trailing P/E

    21.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.97

  • Price/Book (mrq)

    1.38

  • Enterprise Value/Revenue

    1.38

  • Enterprise Value/EBITDA

    9.04

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.65%

  • Return on Assets (ttm)

    4.16%

  • Return on Equity (ttm)

    6.73%

  • Revenue (ttm)

    450.33M

  • Net Income Avi to Common (ttm)

    20.92M

  • Diluted EPS (ttm)

    0.24

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    21.04M

  • Total Debt/Equity (mrq)

    70.39%

  • Levered Free Cash Flow (ttm)

    18.57M

Research Analysis: GHC.F

View More

Company Insights: GHC.F

Research Reports: GHC.F

View More